Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs: a discrete choice experiment among rheumatologists

Monika Hifinger; Mickael Hiligsmann; Sofia Ramiro; Verity Watson; Florian Berghea; Márta Péntek; Andrew Keat; Johan L Severens; Bruno Fautrel; Annelies Boonen

doi:10.1136/rmdopen-2017-000453

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Archive

For authors

About

Podcasts
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

PDF

Rheumatoid arthritis

Original article

Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs: a discrete choice experiment among rheumatologists

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Hifinger M, Hiligsmann M, Ramiro S, et al

Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs: a discrete choice experiment among rheumatologists

RMD Open 2017;3:e000453. doi: 10.1136/rmdopen-2017-000453

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password